Mesothelioma.com - Helping Mesothelioma Patients Since 1996 call
Massachusetts General Hospital Cancer Center

Mass General Brigham Cancer Institute

Affiliated Mesothelioma Doctors
forum Contact Information
55 Fruit Street
Boston, MA  02114
(855) 776-4224
Need Help Contacting this Cancer Center?

History of Mass General Brigham Cancer Institute

Mass General Brigham Cancer Institute in Boston, MA is a leading cancer institution with expert services in hematology and oncology, pediatric hematology and oncology, radiation oncology, surgical oncology, psychiatric oncology, oncology nursing, and oncology social work. Mass General Brigham Cancer Institute is affiliated with an extensive network of cancer programs throughout New England, New York, and Florida. As a national cancer provider, the center offers multidisciplinary care for both adults and children. The highly acclaimed surgeons are experienced in their craft and perform a high volume of cancer surgeries.

In the early 1800s, the Boston area was in great need of a hospital. In response to this need, Reverend John Bartlett collaborated with doctors and other leading citizens to arrange various fund-raising campaigns to raise enough money to begin building the needed facility. On September 3, 1821, the first Boston hospital opened and began administering healthcare to the public. The facility also became the first teaching hospital to be affiliated with the Harvard Medical School within the first year of service. In 1811, a charter was passed by the state legislature to incorporate the Massachusetts General Hospital into Boston. With various gifts and generous donations, the trustees bought the estate in Charlestown and began renovations. The Mass General Brigham Cancer Institute was established in 1986. Kurt Isselbacher, MD, founded the Center for Cancer Research in Boston’s Charlestown Navy Yard in order to study the various stages of cancer.

View a Complete List of Cancer Centers in Our Free Guide Find the right fit for your situation Get Connected

Mesothelioma Care at Mass General Brigham Cancer Institute

Today, the Mass General Brigham Cancer Institute features a Center for Thoracic Cancers that provides treatment to mesothelioma patients. The Mass General Brigham Cancer Institute offers clinical care through a multidisciplinary approach, allowing patients to get personalized treatment from professionals experienced in different areas of cancer care. The compassionate physicians offer personalized care for patients using surgery, chemotherapy, radiation or a multimodal approach using multiple treatment types, a common treatment approach for malignant mesothelioma.

In addition to the Center for Thoracic Cancers, the Mass General Brigham Cancer Institute has more than 37 treatment programs. Along with their expertise in standard mesothelioma treatments like chemotherapy and surgery, the center also has programs around cancer genetics, diagnostic improvements, research to improve patient outcomes from to treatment, nutrition, palliative care and more. The center is well-connected, which enables patients to receive care and second opinions from physicians throughout New England and the southeast.

However, patients do not need to travel to experience cutting-edge treatment options. The physicians at Mass General Brigham Cancer Institute conduct over 400 clinical trials each year at different locations. Participating in these trials offers patients, including mesothelioma patients, access to experimental treatment options.

Mass General Brigham Cancer Institute Specializations

  • Chemotherapy
  • Mesothelioma
  • Targeted immunotherapy
  • Thoracic radiation oncology
  • Thoracic surgery

Mass General Brigham Cancer Institute Accreditations

  • Cancer Center ranked as High Performing according to U.S. News & World Report Best Hospitals report
  • NCI Designated Comprehensive Cancer Center

Mesothelioma Clinical Trials at Mass General Brigham Cancer Institute

The following clinical trials are in progress or actively recruiting participants at Mass General Brigham Cancer Institute:

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Conditions: Mesothelioma
Last Updated: 3/3/2026
Status: Recruiting

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

Conditions: Mesothelioma
Last Updated: 11/14/2025
Status: Recruiting

Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors

Conditions: Mesothelioma
Last Updated: 10/28/2025
Status: Recruiting

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Conditions: Mesothelioma
Last Updated: 5/15/2025
Status: Recruiting

Sources
  1. Massachusetts General Hospital. About the Mass General Cancer Center.

  2. Massachusetts General Hospital. Center for Thoracic Cancers.

  3. Massachusetts General Hospital. Collaborations.

Free mesothelioma guide for patient and and their loved ones Free Mesothelioma Guide